Higher long-term variability of serum uric acid associated with diabetic retinopathy risk: Study
A new study published in the journal of Diabetes Research and Clinical Practice found that patients with type 1 and type 2 diabetes mellitus had a greater chance of developing diabetic retinopathy (DR) if their serum uric acid levels were variable.
With a projected global incidence of 12.2% in 2045, diabetes mellitus (DM), a metabolic condition marked by persistent hyperglycemia brought on by absolute or relative insulin insufficiency, has emerged as one of the most prevalent chronic illnesses. Diabetes-related hyperglycemia and other metabolic irregularities can have a significant impact on the body's organs, resulting in retinopathy, nephropathy, and neuropathy, among other problems.
One significant ocular consequence of diabetes is DR, which affects 22.27 percent of people with diabetes. Additionally, 6.17 percent of people with diabetes have vision-threatening DR (VTDR), making DR the most common cause of visual impairment in people of working age.
Purine metabolism produces uric acid, and high blood uric acid levels are a frequent metabolic change seen in diabetic patients. Several clinical investigations have linked higher serum uric acid levels to diabetic retinopathy. Thus, this study assessed the relationship between the onset and/or severity of diabetic retinopathy (DR) in patients with Type 1 and Type 2 diabetes mellitus (DM) and the variability of serum uric acid (SUA).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.